PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980618
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980618
The global pressure ulcer prevention market was valued at USD 1.17 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, reaching USD 1.69 billion by 2034, exhibiting a CAGR of 4.3% during the forecast period (2026-2034). North America dominated the global market with a 45.30% share in 2025, driven by advanced healthcare infrastructure, high ICU admissions, and increasing geriatric population. The U.S. market is expected to reach USD 604.9 million by 2030, reflecting strong domestic demand.
Pressure ulcers, also known as bedsores, commonly occur among hospitalized, immobile, and elderly patients. Preventive measures are increasingly preferred due to the high treatment cost burden. According to the National Institutes of Health (NIH), hospital-acquired pressure injuries (HAPI) cost between USD 3,300 million and USD 11,000 million annually, highlighting the economic importance of prevention.
COVID-19 Impact
The market experienced a temporary slowdown in 2020 due to reduced non-COVID hospital admissions and supply chain disruptions. U.S. hospital admissions dropped to 69.2% of predicted admissions in April 2020. However, longer hospital stays for COVID patients (8.4 days versus 5.2 days for non-COVID patients) increased pressure ulcer risks, driving preventive device adoption. By April 2021, hospital admissions recovered to 85.5% of predicted levels, restoring market momentum and returning it to pre-pandemic growth trends.
Latest Trends
A major trend shaping the market is the adoption of advanced technologies for prevention. Companies are introducing automated wheelchairs, alternating pressure mattresses, and smart beds that redistribute pressure. In January 2022, Invacare Corporation launched a narrower version of its AVIVA STORM RX power wheelchair designed for pressure ulcer patients.
Hospitals are also integrating motion-detection sensors that alert caregivers when patients remain immobile for extended periods. These technological advancements improve patient safety, reduce complications, and support long-term market growth.
Market Growth Drivers
Elderly individuals suffering from chronic conditions such as COPD, diabetes, and renal failure are at high risk of pressure ulcers due to long-term hospitalization and reduced mobility. According to America's Health Rankings Senior Report (2021), the U.S. population aged 65+ is projected to reach 85.7 million by 2050, nearly 20% of the total population. This demographic shift significantly increases demand for preventive solutions.
Governments and healthcare organizations are promoting awareness campaigns such as the "Stop The Pressure" initiative in the U.K. In October 2020, Talley Group launched the 'STOP THE PRESSURE 2020' educational resource to enhance awareness among healthcare professionals and caregivers. Such initiatives are boosting product adoption globally.
Market Restraints
High product costs remain a key challenge. Advanced prevention products such as alternating air mattresses, air-fluidized beds, and wearable sensors are expensive. A 2021 NCBI cohort study estimated a wearable sensor cost of USD 39,580 per patient annually. In emerging regions such as Asia Pacific, Latin America, and the Middle East & Africa, high device costs limit widespread adoption.
By Product Type
The market is segmented into static support surfaces, dynamic support surfaces, dressings, positioners & protectors, and creams & others.
By End User
North America
North America generated USD 0.53 billion in 2025, maintaining dominance due to high chronic disease burden. The U.S. market is projected to reach USD 0.51 billion by 2026.
Europe
Europe held a substantial share in 2024, supported by awareness campaigns and policy initiatives. By 2026:
Asia Pacific
Asia Pacific is projected to witness the highest CAGR. By 2026:
Latin America & Middle East & Africa
Growth is supported by healthcare infrastructure expansion and awareness collaborations, particularly in GCC countries.
Competitive Landscape
The market is fragmented, led by Stryker, Hill-Rom Holdings, Inc., and Invacare Corporation. Strategic acquisitions strengthen market presence. In December 2021, Hill-Rom was acquired by Baxter, expanding digital health capabilities. Other key players include Arjo, Molnlycke Health Care AB, Savaria, Medline Industries, LP, Coloplast Corp., and Smith & Nephew plc.
Recent developments include product launches such as Medline's Optifoam Gentle EX dressing (2022) and Smith & Nephew's WOUND COMPASS app (2022).
Conclusion
The global pressure ulcer prevention market is poised for steady expansion from USD 1.17 billion in 2025 to USD 1.69 billion by 2034, supported by rising geriatric populations, increasing chronic disease prevalence, technological advancements, and strong government awareness initiatives. Although high device costs remain a restraint, growing emphasis on preventive healthcare and hospital quality standards will continue driving demand. North America will maintain leadership, while Asia Pacific is expected to register the fastest growth. Overall, prevention-focused strategies and innovation in support surfaces and monitoring technologies will define the market's long-term trajectory.
Segmentation By Product Type, End User, and Region
By Product Type * Static Support Surfaces
By End User * Hospitals & Ambulatory Surgery Centers
By Region * North America (By Product Type, By End User, and By Country)